Crossover Randomized Study of Pharmacologic Effects of Ripasudil–Brimonidine Fixed-Dose Combination Versus Ripasudil or Brimonidine

被引:0
作者
Hidenobu Tanihara
Tetsuya Yamamoto
Makoto Aihara
Noriko Koizumi
Hiroomi Minami
Satoshi Kojima
Tomoyuki Isobe
Mizuho Kanazawa
Hideki Suganami
机构
[1] Biei Municipal Hospital,Department of Ophthalmology
[2] Kaiya Eye Clinic,Prof. Kazuo Iwata Memorial Kaijin Glaucoma Center
[3] The University of Tokyo,Department of Ophthalmology
[4] Doshisha University,Department of Biomedical Engineering, Faculty of Life and Medical Sciences
[5] Kowa Company,Pharmaceutical Clinical Development Management Department
[6] Ltd.,Tokyo New Drug Research Laboratories
[7] Kowa Company,Medical Affairs Department
[8] Ltd.,Data Science Center
[9] Kowa Company,undefined
[10] Ltd.,undefined
[11] Kowa Company,undefined
[12] Ltd.,undefined
来源
Advances in Therapy | 2023年 / 40卷
关键词
Conjunctival hyperemia; Corneal endothelial cell; Intraocular pressure; Pupil diameter; Ripasudil–brimonidine fixed-dose combination;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
页码:3559 / 3573
页数:14
相关论文
共 125 条
[1]  
Allison K(2020)Epidemiology of glaucoma: the past, present, and predictions for the future Cureus 12 e1221-e1234
[2]  
Patel D(2017)Global causes of blindness and distance vision impairment 1990–2020: a systematic review and meta-analysis Lancet Glob Health 5 487-497
[3]  
Alabi O(1998)Comparison of glaucomatous progression between untreated patients with normal-tension glaucoma and patients with therapeutically reduced intraocular pressures Am J Ophthalmol 126 498-505
[4]  
Flaxman SR(1998)The effectiveness of intraocular pressure reduction in the treatment of normal-tension glaucoma Am J Ophthalmol 126 429-440
[5]  
Bourne RRA(2000)The Advanced Glaucoma Intervention Study (AGIS): 7. The relationship between control of intraocular pressure and visual field deterioration Am J Ophthalmol 130 701-713
[6]  
Resnikoff S(2002)The Ocular Hypertension Treatment Study: a randomized trial determines that topical ocular hypotensive medication delays or prevents the onset of primary open-angle glaucoma Arch Ophthalmol 120 1268-1279
[7]  
Kass MA(2002)Reduction of intraocular pressure and glaucoma progression: results from the Early Manifest Glaucoma Trial Arch Ophthalmol 120 48-56
[8]  
Heuer DK(2003)Factors for glaucoma progression and the effect of treatment: the Early Manifest Glaucoma Trial Arch Ophthalmol 121 205-209
[9]  
Higginbotham EJ(2007)Fluctuation of intraocular pressure and glaucoma progression in the Early Manifest Glaucoma Trial Ophthalmology 114 671-681
[10]  
Heijl A(2011)A randomized trial of brimonidine versus timolol in preserving visual function: results from the Low-Pressure Glaucoma Treatment Study Am J Ophthalmol 151 702-711